Sucralfate, Lidocaine & Metronidazole
Sucralfate, Lidocaine & Metronidazole formulation is a topical therapeutic combination developed for the treatment of anal fissures, ulcers, wounds, and haemorrhoidal inflammation. It provides a three-way action — healing, pain relief, and infection control.
The formulation soothes the affected area, reduces pain and inflammation, and accelerates tissue regeneration, making it suitable for both acute and chronic wound management.
Sucralfate: Acts as a cytoprotective and wound-healing agent, forming a barrier over damaged mucosa and promoting epithelial repair.
Lidocaine: A local anaesthetic that provides rapid pain and burning relief by temporarily numbing nerve endings at the site of application.
Metronidazole: A broad-spectrum antimicrobial agent effective against anaerobic bacteria and protozoa, helping prevent or treat infection in wounds and ulcers.
This synergistic combination ensures effective management of pain, infection, and healing in mucosal and dermal conditions.
Treatment of anal fissures and haemorrhoidal inflammation.
Promotes healing in non-healing ulcers and post-surgical wounds.
Used in infected wounds, bed sores, and burns to prevent bacterial growth.
Provides local pain relief and reduces discomfort associated with lesions.
Aids in faster recovery of damaged mucosal and epithelial tissues.
Triple-action therapy: healing, analgesic, and antimicrobial effects.
Forms a protective barrier, preventing irritation from external fact.
Provides instant soothing and pain relief through Lidocaine.
Accelerates tissue granulation and re-epithelialisation.
Suitable for proctological, dermatological, and post-surgical care.
Can be used safely for long-term management under medical supervision.
